{rfName}
R-

Indexed in

License and use

Altmetrics

Analysis of institutional authors

Arnan Sangerman, MontserratAuthorGonzalez Barca, Eva MariaAuthor
Share
Publications
>
Article

R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study

Publicated to:Haematologica. 93 (12): 1829-1836 - 2008-01-01 93(12), DOI: 10.3324/haematol.13440

Authors: Martín A, Conde E, Arnan M, Canales MA, Deben G, Sancho JM, Andreu R, Salar A, García-Sanchez P, Vázquez L, Nistal S, Requena MJ, Donato EM, González JA, León A, Ruiz C, Grande C, González-Barca E, Caballero MD, Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea (GEL/TAMO Cooperative Group).

Affiliations

Complejo Hospitalario de Zamora, Spain - Author
Department of Hematology, Complejo Hospitalario de Zamora, Avenida de Requejo 35, Zamora 49022, Spain - Author
Hospital Carlos Haya, Málaga, Spain - Author
Hospital Clínico de Madrid, Spain - Author
Hospital del Mar, Barcelona, Spain - Author
Hospital Doce de Octubre, Madrid, Spain - Author
Hospital Dr. Peset, Valencia, Spain - Author
Hospital Duran I Reynals, L'Hospitalet de Llobregat, Spain - Author
Hospital General de Castellón, Spain - Author
Hospital General de Jerez, Jerez de la Frontera, Spain - Author
Hospital Germans Trias i Pujol, Badalona, Spain - Author
Hospital Juan Canalejo, La Coruña, Spain - Author
Hospital La Paz, Madrid, Spain - Author
Hospital Marques de Valdecilla, Santander, Spain - Author
Hospital Severo Ochoa, Leganés, Spain - Author
Hospital Universitario de Getafe, Spain - Author
Hospital Universitario de Salamanca, Spain - Author
Hospital Virgen del Puerto, Plasencia, Spain - Author
See more

Abstract

Keywords
Diffuse large b-cell lymphomaR-eshapRituximabSalvage therapy

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Haematologica due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2008, it was in position 9/62, thus managing to position itself as a Q1 (Primer Cuartil), in the category Hematology.

From a relative perspective, and based on the normalized impact indicator calculated from the Field Citation Ratio (FCR) of the Dimensions source, it yields a value of: 24.23, which indicates that, compared to works in the same discipline and in the same year of publication, it ranks as a work cited above average. (source consulted: Dimensions May 2025)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-05-08, the following number of citations:

  • WoS: 130
  • Scopus: 158
  • Europe PMC: 93
  • OpenCitations: 158
Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-05-08:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 139.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 142 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 6.5.
  • The number of mentions on the social network X (formerly Twitter): 1 (Altmetric).

It is essential to present evidence supporting full alignment with institutional principles and guidelines on Open Science and the Conservation and Dissemination of Intellectual Heritage. A clear example of this is:

  • The work has been submitted to a journal whose editorial policy allows open Open Access publication.